Cleared Abbreviated

K042173 - COULTER A T 5DIFF CAP PIERCE (CP)

K042173 is the FDA 510(k) clearance for COULTER A T 5DIFF CAP PIERCE (CP) by Beckman Coulter, Inc.. It is a Class 2 Hematology device (product code GKZ) cleared through the Abbreviated 510(k) pathway after a 62-day FDA review.

K042173 · Beckman Coulter, Inc. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2004
Decision
62d
Days
Class 2
Risk

K042173 is an FDA 510(k) clearance for the COULTER A T 5DIFF CAP PIERCE (CP). Classified as Counter, Differential Cell (product code GKZ), Class II - Special Controls.

Submitted by Beckman Coulter, Inc. (Miami, US). The FDA issued a Cleared decision on October 12, 2004 after a review of 62 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 864.5220 - the FDA hematology device framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: Standards-based predicate clearance. Standards-verified equivalence. The Abbreviated pathway signals strong alignment with FDA-recognized performance standards - typically associated with lower review burden and faster clearance cycles.

View all Beckman Coulter, Inc. devices

Submission Details

510(k) Number K042173 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 11, 2004
Decision Date October 12, 2004
Days to Decision 62 days
Submission Type Abbreviated
Review Panel Hematology (HE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
51d faster than avg
Panel avg: 113d · This submission: 62d
Pathway characteristics
Standards-based clearance path.

Device Classification

Product Code GKZ Counter, Differential Cell
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 864.5220
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - GKZ Counter, Differential Cell

All 193
Devices cleared under the same product code (GKZ) and FDA review panel - the closest regulatory comparables to K042173.
COULTER LH 750 HEMATOLOGY ANALYZER
K050057 · Beckman Coulter, Inc. · Feb 2005
FLOWCARE PLG CD4 REAGENT
K043215 · Beckman Coulter, Inc. · Jan 2005
MODIFICATION TO COULTER LH 500 HEMATOLOGY ANALYZER
K042724 · Beckman Coulter, Inc. · Oct 2004
BAYER ADVIA 2120 HEMATOLOGY ANALYZER WITH AUTOSLIDE SYSTEM
K042251 · Bayer Healthcare, LLC · Sep 2004
COULTER LH 750 HEMATOLOGY ANALYZER
K032342 · Beckman Coulter, Inc. · Sep 2003
ADVIA 60 HEMATOLOGY ANALYZER
K032524 · Bayer Healthcare, LLC · Sep 2003